An exergy-based multi-objective optimisation model for energy retrofit strategies in non-domestic buildings

While the building sector has a significant thermodynamic improvement potential, exergy analysis has been shown to provide new insight for the optimisation of building energy systems. This paper presents an exergy-based multi-objective optimisation tool that aims to assess the impact of a diverse range of retrofit measures with a focus on non-domestic buildings. EnergyPlus was used as a dynamic calculation engine for first law analysis, while a Python add-on was developed to link dynamic exergy analysis and a Genetic Algorithm optimisation process with the aforementioned software. Two UK archetype case studies (an office and a primary school) were used to test the feasibility of the proposed framework. Different measures combinations based on retrofitting the envelope insulation levels and the application of different HVAC configurations were assessed. The objective functions in this study are annual energy use, occupants' thermal comfort, and total building exergy destructions. A large range of optimal solutions was achieved highlighting the framework capabilities. The model achieved improvements of 53% in annual energy use, 51% of exergy destructions and 66% of thermal comfort for the school building, and 50%, 33%, and 80% for the office building. This approach can be extended by using exergoeconomic optimisation

The Ubiquitin System in Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common form of dementia, most prevalent in the elderly population and has a significant impact on individuals and their family as well as the health care system and the economy. While the number of patients affected by various forms of dementia including AD is on the increase, there is currently no cure. Although genome-wide association studies have identified genetic markers for familial AD, the molecular mechanisms underlying the initiation and development of both familial and sporadic AD remain poorly understood. Most neurodegenerative diseases and in particular those associated with dementia have been defined as proteinopathies due to the presence of intra- and/or extracellular protein aggregates in the brain of affected individuals. Although loss of proteostasis in AD has been known for decades, it is only in recent years that we have come to appreciate the role of ubiquitin-dependent mechanisms in brain homeostasis and in brain diseases. Ubiquitin is a highly versatile post-translational modification which regulates many aspects of protein fate and function, including protein degradation by the Ubiquitin–Proteasome System (UPS), autophagy-mediated removal of damaged organelles and proteins, lysosomal turnover of membrane proteins and of extracellular molecules brought inside the cell through endocytosis. Amyloid-β (Aβ) fragments as well as hyperphosphorylation of Tau are hallmarks of AD, and these are found in extracellular plaques and intracellular fibrils in the brain of individuals with AD, respectively. Yet, whether it is the oligomeric or the soluble species of Aβ and Tau that mediate toxicity is still unclear. These proteins impact on mitochondrial energy metabolism, inflammation, as well as a number of housekeeping processes including protein degradation through the UPS and autophagy. In this chapter, we will discuss the role of ubiquitin in neuronal homeostasis as well as in AD; summarise crosstalks between the enzymes that regulate protein ubiquitination and the toxic proteins Tau and Aβ; highlight emerging molecular mechanisms in AD as well as future strategies which aim to exploit the ubiquitin system as a source for next-generation therapeutics.<br/